AWM Investment Company’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

AWM Investment Company’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-185,300	Closed	-$676K	–	112
2016 Q4	$676K	Hold	185,300	–	–	0.13%	85
2016 Q3	$708K	Sell	185,300 -26,000	-12%	-$118K	0.13%	86
2016 Q2	$1.1M	Sell	211,300 -38,700	-15%	-$221K	0.24%	77
2016 Q1	$1.2M	Hold	250,000	–	–	0.25%	73
2015 Q4	$1.17M	Buy	250,000 +30,000	+14%	+$130K	0.23%	73
2015 Q3	$816K	Buy	220,000 +20,000	+10%	+$139K	0.16%	96
2015 Q2	$1.71M	Buy	+200,000	New	+$1.99M	0.24%	88

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

AWM Investment Company's CPHR Position: Q1 2017 in Review

AWM Investment Company sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q1 2017, closing a stake of 185,300 shares — an estimated $676K sold.

AWM Investment Company first reported a position in CPHR in Q2 2015 and held it in 7 quarters. The position peaked at $1.71M in Q2 2015. 1 fund tracked by Wall St. Rank holds CPHR as of Q1 2017.

AWM Investment Company reported no remaining Cipher Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
AWM Investment Company sold 185,300 Cipher Pharmaceuticals Inc. shares in Q1 2017, an estimated $676K.
AWM Investment Company first reported a position in Cipher Pharmaceuticals Inc. in Q2 2015 and held it in 7 quarters.
AWM Investment Company's Cipher Pharmaceuticals Inc. position peaked at $1.71M in Q2 2015.
1 fund tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q1 2017.

Based on AWM Investment Company's 13F filing for Q1 2017, filed 12 May 2017.